Related Experiment Videos
Vitamin D deficiency and chronic lung disease
Christopher R Gilbert1, Seth M Arum, Cecilia M Smith
1Department of Pulmonary and Critical Care Medicine, Thomas Jefferson University Hospital, Philadelphia 19107, USA. accrg0@hotmail.com
Canadian Respiratory Journal
|June 27, 2009
Summary
Vitamin D deficiency is common, especially in chronic lung disease patients. Low vitamin D levels may negatively impact lung function and contribute to disease development.
Area of Science:
- Pulmonary Medicine
- Nutritional Science
- Immunology
Background:
- Vitamin D deficiency is a growing global health concern.
- Patients with chronic lung diseases (asthma, cystic fibrosis, COPD, interstitial pneumonia) show higher risks of vitamin D deficiency.
- Emerging evidence suggests vitamin D has anti-inflammatory roles beyond calcium and phosphate regulation.
Purpose of the Study:
- To review the literature on vitamin D deficiency in chronic lung disease.
- To explore vitamin D's anti-inflammatory properties and its influence on lung function.
- To examine the potential immune and genetic links between vitamin D and chronic lung diseases.
Main Methods:
- Literature review of current studies on vitamin D and chronic lung disease.
- Analysis of vitamin D's role in inflammatory pathways affecting the lungs.
- Examination of genetic associations between vitamin D and lung conditions.
Main Results:
- Vitamin D deficiency is prevalent in individuals with chronic lung conditions.
- Vitamin D exhibits anti-inflammatory effects relevant to lung health.
- Vitamin D status may influence lung fibroproliferation, remodeling, and overall function.
- Associations exist between vitamin D deficiency and reduced pulmonary function tests.
Conclusions:
- Vitamin D deficiency is a significant issue in chronic lung disease patients.
- Vitamin D's anti-inflammatory and potential immune/genetic roles are crucial in lung disease pathogenesis.
- Maintaining adequate vitamin D levels may be important for pulmonary health and function.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation